Developing products for the diagnosis of acute infectious and autoimmune diseases
Lophius Biosciences has raised €2.2M across 1 funding round from 3 investors, most recently a Early VC round in Mar 2017. Based in Regensburg, Germany; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Early VC |
| €2.2M |
| Bayern Kapital,VRD,Wolf Biotech |
| View deal → |
